Drug : Crizotinib:Plx-4032 (2:1 Mol-Mol)
CTRP2 Name
: crizotinib:PLX-4032 (2:1 mol/mol)
Dataset : All
Synonyms :
Targets : ALK;MET;BRAF
Pathways : inhibitor of c-MET and ALK;inhibitor of BRAF
Information Cards
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including drug name, cell line name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Drug name | Cellosaurus ID | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| crizotinib:PLX-4032 (2:1 mol-mol) | CAS-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KPL-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MKN1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | 253J-BV | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BFTC-905 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BFTC-909 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CAL-120 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CAL-29 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CAL-62 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HUCC-T1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NMC-G1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RPMI-7951 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | 253J | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | ALL-SIL | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HDQ-P1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SIMA | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-489 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-626 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-738 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-878 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TUHR4TKB | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | ACC-MESO-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | B-CPAP | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CGTH-W-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | COLO680N | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | ECC12 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC95 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | JMSU-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RH41 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | WSU-DLCL2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | 23132-87 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | 8305C | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BHY | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | GSU | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | JIMT-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KMRC-20 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OUMS-23 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-1076 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-1196 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-8 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | A-375 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | A-549 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H2009 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-201 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SUIT-2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-1079 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | COLO741 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | DEL | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC15 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KP-4 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | LU-99 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1155 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1581 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H2106 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H358 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | DLD-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | EM-2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | JURL-MK1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | P12-ICHIKAWA | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KE-37 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KMS-21-BM | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | LI-7 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MHH-NB-11 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MOLM-13 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1975 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H28 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | 639V | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BXPC-3 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CML-T1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | GSS | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC366 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KURAMOCHI | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | LS411N | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | LS513 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | ONCO-DG-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | ONS-76 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-CO-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SW48 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | VM-CUB-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BEN | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CFPAC-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC78 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HT | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KU-19-19 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1299 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H727 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCO2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OVTOKO | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | P31-FUJ | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | PEER | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RPMI-8402 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SHP-77 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-1077 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-620 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SU-DHL-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | COLO205 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | EHEB | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KI-JK | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KMM-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | LCLC-103H | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MKN45 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H2405 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H650 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OS-RC-2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OVSAHO | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | QGP-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RL95-2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-1041 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-1066 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SW1353 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-213 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | 8505C | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CALU-3 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | DAOY | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | GB-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC1171 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC44 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H211 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RERF-LC-A1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SBC-5 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SF126 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-119 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-81 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-182 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TCCSUP | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CAMA-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | DETROIT562 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HEC-1-B | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HEP3B2.1-7 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HSC-3 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MCF-7 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-1105 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | U-87MGATCC | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | 22RV1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | 769-P | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | COLO699 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | DOV13 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | ES2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC1806 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC1954 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HPAF-II | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KHM-1B | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OVISE | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | JVM-3 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-C2A | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | U2OS | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | 5637 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CAL-12T | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC1588 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC1833 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC2279 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KE-97 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KP-3 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KU812 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KYSE-140 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NALM-6 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NUGC-4 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TT | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | AGS | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCT116 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HEC-108 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HEC-59 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HMC-1-8 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HT-29 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | ISHIKAWA(HERAKLIO)02ER- | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | JHOC-5 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KYSE-180 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | LS180 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MELHO | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MHH-ES-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MOR-CPR | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H460 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC2108 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC827 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HEC-251 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HEC-265 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HEC-6 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HEL | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | JHUEM-2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | JURKAT | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KCL-22 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KE-39 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KM-H2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | LAMA-84 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H2030 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-719 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC1569 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KLE | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KMS-26 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KMS-27 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1838 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H292 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-MEL-1 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC1937 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HDLM-2 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HUH-28 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MV4-11 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H526 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H69 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H929 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-N87 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | PF-382 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SF295 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-478 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BHT-101 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CAL-51 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC1395 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HT115 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | LN-18 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | LN-229 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1734 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H2291 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RERF-LC-AD1 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-1214 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-46 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-5 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-668 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-899 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TE-10 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TE-4 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TE-9 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | YD-10B | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | YD-15 | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | YD-38 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KNS-60 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KNS-81 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | ML-1[HUMANLEUKEMIA] | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H2228 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H2452 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H2444 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H226 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | PC-14 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RS4;11 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SJSA-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-MM-2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-761 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SU.86.86 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SW1271 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TE-6 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TE8 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | ECC10 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC1195 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HPB-ALL | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KMS-18 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KMS-12-BM | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KMS-34 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KYO-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MONO-MAC-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1650 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H446 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | REC-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-410 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SUP-T11 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TALL-1[HUMANADULTT-ALL] | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | YD-8 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CHP-126 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HS944.T | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | L-540 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | LOU-NH91 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MOLM-6 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MOLT-16 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H889 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NU-DUL-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RCH-ACV | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TUHR10TKB | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | FU-OV-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | JK1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MHH-CALL-4 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MSTO-211H | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H661 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | P3HR-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RI-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SU-DHL-10 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SU-DHL-8 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SW1573 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | A2780 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CL-11 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KARPAS-620 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KYSE-410 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | LCLC-97TM1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MOLP-2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1355 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1573 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1666 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H2087 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KALS-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SW1710 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BV-173 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CAL-78 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | EPLC-272H | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | IGROV-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RH18 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KM12 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KMS-11 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | L-363 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MCAS | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MHH-CALL-3 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MKN74 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RKO | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SCC-25 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNG-M | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SR | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | AMO1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HEC-50B | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MC116 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MOLM-16 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SU-DHL-4 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SU-DHL-6 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CW-2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H2052 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H520 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-398 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | DBTRG-05MG | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KELLY | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MDA-MB-231 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | ME1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MELJUSO | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NB1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1373 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1792 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H2122 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H508 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OVCAR-4 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OVCAR-8 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | PL21 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RPMI-8226 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RT-112 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SKM-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SUP-T1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | EFE-184 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | GAMG | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HEC-151 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HSC-4 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HUH-6 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | PATU8902 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-840 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-C5 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SQ-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SW1088 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | THP-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TYK-NU | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | U-937 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | UM-UC-3 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | LS123 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-MEL-28 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-MEL-31 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-MEL-5 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-407 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-61 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CALU-6 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CAOV-3 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | EBC-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HEYA8 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HT-1376 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HT-55 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HUP-T4 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | IPC-298 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | L3.3 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | LOX-IMVI | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1755 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OVK18 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-LU-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-MEL-30 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SW620 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | VMRC-RCW | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC1143 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | LOVO | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MDST8 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MM1.S | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1184 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | PK-59 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RKN | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RMG-I | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RT-4 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-OV-3 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TE-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | WM1799 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | WM793 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | G-361 | CTRP2 | 0.0015 | 3.1000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HELA | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HEP-G2 | CTRP2 | 0.0015 | 3.1000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HPAC | CTRP2 | 0.0015 | 12.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HS852.T | CTRP2 | 0.0015 | 12.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HS936.T | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KYSE-70 | CTRP2 | 0.0015 | 3.1000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | LXF289 | CTRP2 | 0.0015 | 12.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1435 | CTRP2 | 0.0015 | 12.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H2023 | CTRP2 | 0.0015 | 3.1000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H2126 | CTRP2 | 0.0015 | 12.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NUGC-3 | CTRP2 | 0.0015 | 3.1000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | PANC05.04 | CTRP2 | 0.0015 | 3.1000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OAW28 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TCC-PAN2 | CTRP2 | 0.0015 | 3.1000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | YAPC | CTRP2 | 0.0015 | 3.1000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | ZR-75-1 | CTRP2 | 0.0015 | 3.1000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | C2BBE1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CHAGO-K-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | COLO668 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | COV362 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | DV-90 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | EFO-27 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HD-MY-Z | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H2170 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H647 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H810 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OCI-AML-3 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | PATU8988S | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MIAPACA-3 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TE-5 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | UACC-257 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | UACC-62 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BICR6 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT145 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT179 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | EC-GI-10 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | EFO-21 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | FTC-133 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | JHUEM-3 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | LK2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | LNCAPCLONEFGC | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | LS1034 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MKN7 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC1428 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H2029 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OE21 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SH-10-TC | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-449 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | T3M-10 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT112 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT164 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CCF-STTG1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | COLO800 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | DK-MG | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | GP2D | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1869 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC38 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | IA-LM | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | JHOM-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | JHUEM-7 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | JL-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KYSE-450 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | LC-1-SQ-SF | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RCM-1[HUMANESC] | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-685 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | VMRC-LCD | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT224 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT-549 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC202 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | H-STS | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | K029AX | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KYSE-520 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1623 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H716 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OE19 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OE33 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | N2A-PK1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | PK-45H | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | P-STS | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RERF-LC-AD2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | U-CH1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | 697 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | A3-KAWAKAMI | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CA46 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | COR-L279 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | COR-L51 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | DU4475 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | EB1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | EOL-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | GA-10 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MOLT-3 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NAMALWA | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OPM-2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | PFEIFFER | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SUP-M2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | COLO829 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | DAN-G | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | EJM | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | GRANTA-519 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC1500 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | IGR-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H841 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OCI-LY10 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OCI-LY19 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OCI-LY3 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | U-118MG | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | COR-L88 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | LU-65 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H2081 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H2141 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | A-172 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | COV644 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | IM95 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | J82 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H23 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RD | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-UT-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | T98G | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BECKER | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HS611.T | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | JHH-4 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KARPAS-422 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KMRC-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | LP-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MDA-MB-468 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SH4 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-HEP-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SUP-HD1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | AN3-CA | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | ACHN | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CMK | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | EN | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KASUMI-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H2342 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OV-90 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RERF-LC-MS | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RPMI-6666 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-N-MC | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | A-253 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BC-3C | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | C32[HUMANMELANOMA] | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CAL-85-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | COLO684 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HS746.T | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HSC-2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HT-144 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | VMRC-RCZ | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MES-SA | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1105 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H322 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OAW42 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | PSN1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | T24 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TE441.T | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TT2609-C02 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CAKI-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | COR-L105 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | DMS273 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | ESS-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | G-402 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HOS | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HS294T | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | JHH-6 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MFE-319 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MOLP-8 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1339 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OV7 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | PANC03.27 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | PLC-PRF-5 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SCC-9 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-LMS-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-MEL-2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | JHH-2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | A-498 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HLF | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | JHH-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OV56 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | PANC02.03 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-475 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TOV-21G | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | 647V | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | 8-MG-BA | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | A101D | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | A2058 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | ASPC-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CAKI-2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CAL-27 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | COLO792 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | FTC-238 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | GMS-10 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | GOS-3 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HMCB | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HUH-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | IGR-39 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | IST-MES1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | M059K | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | PATU8988T | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SCABER | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-N-SH | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TM-31 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | YH-13 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | A-673 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | DU145 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | FADU | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC4006 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HS683 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HS729.T | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HT-1080 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | JHH-5 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | JHUEM-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MEWO | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MIAPACA-2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCC-STC-K140 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-MES-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-N-DZ | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SW579 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | WM115 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | WM266-4 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT-20 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CAL-54 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CAPAN-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CHP-212 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HS895.T | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KATOIII | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KMRC-2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KNS-42 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MPP89 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1693 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | PANC04.03 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | PE-CA-PJ49 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-MEL-24 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-N-AS | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TE617.T | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | YKG-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BL-70 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | COR-L95 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | D283MED | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HL-60 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HUP-T3 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | IMR-32 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KO52 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MEC1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1092 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H2196 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NH-6 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OCI-M1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SIG-M5 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TF-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | 786-O | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | A4-FUKUDA | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCT15 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HEL92.1.7 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HUNS1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | JHOS-2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | K-562 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1341 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1568 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1703 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H838 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-N-FI | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TE-11 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | DAUDI | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HT-1197 | CTRP2 | 0.0015 | 0.1900 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | LUDLU-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1915 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1944 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H522 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | PE-CA-PJ41(CLONED2) | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | PE-CA-PJ15 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RVH-421 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SET-2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-16 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TOV-112D | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | DB | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC1419 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC-56 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HS839.T | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H2110 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | PE-CA-PJ34(CLONEC12) | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-387 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-503 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-869 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-C1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SW1990 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SW948 | CTRP2 | 0.3900 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TE15 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | UM-UC-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | WM88 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | WM983B | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | ZR-75-30 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CI-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CJM[HUMANMELANOMA] | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HUG1-N | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | JEKO-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | JM1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KP-2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | LMSU | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MG-63 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MINO | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MOTN-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RL | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-MEL-3 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | ST486 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SUP-B15 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TC71 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BICR18 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BICR22 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BICR31 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | COLO678 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | G-401 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HS888.LU | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KP-N-YN | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1395 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-423 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SW1417 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SW1783 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | VCAP | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | DMS454 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | GCT | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC2935 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HOP-62 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H747 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OVCAR-5 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SF268 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SF539 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TUHR14TKB | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | U-251MG | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | DMS53 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HEC-1-A | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | IGR-37 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KNS-62 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1563 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OC314 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | UO-31 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BICR56 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CAL-33 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CALU-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | CAPAN-2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | DMS114 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | EKVX | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC1438 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCT8 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HOP-92 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KYM-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KYSE-30 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KYSE-510 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | L-428 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MDA-MB-361 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MFE-296 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NU-DHL-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNB-75 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-216 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BICR16 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | F-36P | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | JJN-3 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KASUMI-2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KG-1-C | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KMS-20 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KYSE-150 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | OCI-AML-5 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | PANC08.13 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-601 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-C4 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | T-47D | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | T84 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TE-14 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | U266B1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | 42-MG-BA | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT139 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT159 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT187 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT228 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT231 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT239 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT-474 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | COV434 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | DND-41 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | G-292CLONEA141B1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HCC2218 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HS766T | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KMRC-3 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | M-07E | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-BR-3 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SNU-1033 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | A-204 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | AML-193 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HGC-27 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HS578BST | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HS934.T | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HS688(A).T | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1793 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SCC-4 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-ES-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HS888.T | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | MDA-MB-453 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H660 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SAOS-2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | U-BLC1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT248 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | NCI-H1694 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SEM | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HS822.T | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | HS940.T | CTRP2 | 0.0030 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | KMBC-2 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | RCC10RGB | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SK-N-BE(2) | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | AU565 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | COLO320 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | PANC10.05 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT131 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT147 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT172 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT216 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT232 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT245 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT271 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT286 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT320 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT328 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT330 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT333 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT340 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT359 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT416 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT422 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT428 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT440 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT444 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT482 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT498 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT504 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | 2004 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | ASKA-SS | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT-12 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | BT-16 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SW982 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | SYO-1 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TM87-16 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | TTC-709 | CTRP2 | 0.0015 | 50.0000 |
|
| crizotinib:PLX-4032 (2:1 mol-mol) | YAMATO-SS | CTRP2 | 0.0015 | 50.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Cell lines with highest and lowest IC50
Cell lines with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Cell lines with highest and lowest IC90
Cell lines with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Cell lines with highest and lowest AUC
Cell lines with highest and lowest AUC
Associated Genes (Mutation)
Genes with the largest and lowest Racksum’s effect sizes, calculated by comparing IC50 between the mutant and wide type cell lines using cell lines from
pancan data.
Associated Genes (Gene Expression)
Genes with the highest and lowest Spearman correlations, calculated by comparing gene expression and IC50 across cell lines from
pancan data.